CoChat
Sign Up
Cited by 101Epigenetics and DNA MethylationHepatocellular Carcinoma Treatment and PrognosisCancer-related molecular mechanisms research

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma

Open access
Hayashi, Masamichi, Nomoto, Shuji, Hishida, Mitsuhiro, Inokawa, Yoshikuni, Kanda, Mitsuro, Okamura, Yukiyasu, Nishikawa, Yoko, Tanaka, Chie, Kobayashi, Daisuke, Yamada, Suguru, Nakayama, Goro, Fujii, Tsutomu, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Takeda, Shin, Kodera, Yasuhiro·2014·BMC Cancer
DOI 10.1186/1471-2407-14-108PMC PMC4015503
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death especially among Asian and African populations. It is urgent that we identify carcinogenesis-related genes to establish an innovative treatment strategy for this disease. METHODS: Triple-combination array analysis was performed using one pair each of HCC and noncancerous liver samples from a 68-year-old woman. This analysis consists of expression array, single nucleotide polymorphism array and methylation array. The gene encoding collagen type 1 alpha 1 (COL1A1) was identified and verified using HCC cell lines and 48 tissues from patients with primary HCC. RESULTS: Expression array revealed that COL1A1 gene expression was markedly decreased in tumor tissues (log2 ratio -1.1). The single nucleotide polymorphism array showed no chromosomal deletion in the locus of COL1A1. Importantly, the methylation value in the tumor tissue was higher (0.557) than that of the adjacent liver tissue (0.008). We verified that expression of this gene was suppressed by promoter methylation. Reactivation of COL1A1 expression by 5-aza-2'-deoxycytidine treatment was seen in HCC cell lines, and sequence analysis identified methylated CpG sites in the COL1A1 promoter region. Among 48 pairs of surgical specimens, 13 (27.1%) showed decreased COL1A1 mRNA expression in tumor sites. Among these 13 cases, 10 had promoter methylation at the tumor site. The log-rank test indicated that mRNA down-regulated tumors were significantly correlated with a poor overall survival rate (P = 0.013). CONCLUSIONS: Triple-combination array analysis successfully identified COL1A1 as a candidate survival-related gene in HCCs. Epigenetic down-regulation of COL1A1 mRNA expression might have a role as a prognostic biomarker of HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2407-14-108

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Primary data for surgical samples from a 68-year-old woman (study patient). a. Down-regulation of the COL1A1 gene was seen in the tumor tissue compared with the adjacent noncancerous liver tissue (146 bp). Reverse transcriptase polymerase chain reaction (RT-PCR) for β-actin was performed to normalize the quantity of cDNA. b Copy number analysis of chromosome 17. There was no deletion or amplification at the COL1A1 gene locus (17q21.33). c Immunohistochemical staining of COL1A1 protein showed that tumor tissue components showed almost no staining compared with adjacent noncancerous tissue components (200×).
Figure 1 Primary data for surgical samples from a 68-year-old woman (study patient). a. Down-regulation of the COL1A1 gene was seen in the tumor tissue compared with the adjacent noncancerous liver tissue (146 bp). Reverse transcriptase polymerase chain reaction (RT-PCR) for β-actin was performed to normalize the quantity of cDNA. b Copy number analysis of chromosome 17. There was no deletion or amplification at the COL1A1 gene locus (17q21.33). c Immunohistochemical staining of COL1A1 protein showed that tumor tissue components showed almost no staining compared with adjacent noncancerous tissue components (200×).CC BY · PubMed Central
Figure 2 Analysis of COL1A1 methylation and expression. a Promoter methylation status of the study patient’s samples was examined. Methylation-specific PCR (MSP) and unmethylation-specific PCR (UMSP) were performed. Only tumor tissue had promoter methylation. b Promoter methylation status of the COL1A1 gene six hepatcellular carcinoma (HCC) cell lines. Complete methylation was detected in the cell line HLE; partial methylation in HLF, HuH2, and SK-Hep1; and complete unmethylation in Hep3B and HuH7. cCOL1A1 expression was reactivated in HLE, HLF, HuH2, and SK-Hep1 by 5-aza-2′-deoxycytidine (5-aza-dC) treatment. β-Actin was used as the normalization gene. d COL1A1 protein expression was confirmed by western blotting. Very weak or no band was detected in the cell lines with positive promoter methylation. β-Actin was used as the normalization gene.
Figure 2 Analysis of COL1A1 methylation and expression. a Promoter methylation status of the study patient’s samples was examined. Methylation-specific PCR (MSP) and unmethylation-specific PCR (UMSP) were performed. Only tumor tissue had promoter methylation. b Promoter methylation status of the COL1A1 gene six hepatcellular carcinoma (HCC) cell lines. Complete methylation was detected in the cell line HLE; partial methylation in HLF, HuH2, and SK-Hep1; and complete unmethylation in Hep3B and HuH7. cCOL1A1 expression was reactivated in HLE, HLF, HuH2, and SK-Hep1 by 5-aza-2′-deoxycytidine (5-aza-dC) treatment. β-Actin was used as the normalization gene. d COL1A1 protein expression was confirmed by western blotting. Very weak or no band was detected in the cell lines with positive promoter methylation. β-Actin was used as the normalization gene.CC BY · PubMed Central
Figure 3 Direct sequencing of bisulfite-treated HCC cell lines. The location was between −12 and +35 bp from the transcription initiation site. All CG dinucleotides were almost unmethylated (blue circles) in Hep3B. In contrast, all CG dinucleotides were completely methylated (red circles) in HLE.
Figure 3 Direct sequencing of bisulfite-treated HCC cell lines. The location was between −12 and +35 bp from the transcription initiation site. All CG dinucleotides were almost unmethylated (blue circles) in Hep3B. In contrast, all CG dinucleotides were completely methylated (red circles) in HLE.CC BY · PubMed Central
Figure 4 Promoter methylation status in 48 tumor tissues and matched noncancerous liver tissues. a A total of 20 tumor tissues and 11 noncancerous tissues showed promoter methylation. b MSP and UMSP results of two representative cases. c The 48 cases were divided into13 COL1A1 expression down-regulated cases and 35 up-regulated cases in tumor tissues. Promoter methylated cases were indicated by red lines. Promoter methylation and the mRNA expression pattern were significantly correlated (P = 0.002).
Figure 4 Promoter methylation status in 48 tumor tissues and matched noncancerous liver tissues. a A total of 20 tumor tissues and 11 noncancerous tissues showed promoter methylation. b MSP and UMSP results of two representative cases. c The 48 cases were divided into13 COL1A1 expression down-regulated cases and 35 up-regulated cases in tumor tissues. Promoter methylated cases were indicated by red lines. Promoter methylation and the mRNA expression pattern were significantly correlated (P = 0.002).CC BY · PubMed Central
Figure 5 Overall survival curves for down-regulated and up-regulated cases of COL1A1 mRNA expression in tumor tissues. Red line: down-regulated (n = 13). Blue line: up-regulated (n = 35). According to the log-rank test, down-regulated cases were significantly correlated with poor overall survival (P = 0.013).
Figure 5 Overall survival curves for down-regulated and up-regulated cases of COL1A1 mRNA expression in tumor tissues. Red line: down-regulated (n = 13). Blue line: up-regulated (n = 35). According to the log-rank test, down-regulated cases were significantly correlated with poor overall survival (P = 0.013).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Saito Y, Hibino S, Saito H: Alterations of epigenetics and microRNA in hepatocellular carcinoma. Hepatol Res. in press

Cited by

Sorted by citations

See all 101

Related

See all

Metadata

Authors
Hayashi, M., Nomoto, S., Hishida, M., Inokawa, Y., Kanda, M., Okamura, Y., Nishikawa, Y., Tanaka, C., Kobayashi, D., Yamada, S., Nakayama, G., Fujii, T., Sugimoto, H., Koike, M., Fujiwara, M., Takeda, S., & Kodera, Y.
Affiliations
Nagoya University (JP)
Corresponding author
Nomoto, Shuji
ORCID
Venue
BMC Cancer
Publisher
Springer Science and Business Media LLC
Published
2014-02-19
Volume
14
Issue
1
Pages
108-108
ISSN
1471-2407 (ISSN-L)
DOI
10.1186/1471-2407-14-108
PMC
PMC4015503
OpenAlex
W2152909439
Cited by
101
References
43
Citations by year
2026: 2 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 17 · 2021: 16 · 2020: 14 · 2019: 10 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 4 · 2014: 1
FWCI
2.60
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (22591427)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
hepatocellular carcinoma, COL1A1, promoter methylation, epigenetic silencing, gene downregulation, prognostic factors, overall survival, decitabine, single nucleotide polymorphism array, DNA methylation arrays
MeSH terms
Collagen Type I, alpha 1 Chain, Aged, Base Sequence, Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Molecular Sequence Data, Survival Rate, Collagen Type I, Cell Line, Tumor, Genetic Association Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review